KeyBank National Association
SAGE

KeyBank National Association’s Sage Therapeutics SAGE Stock Holding History

KeyBank National Association’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,868
Closed -$264K – 1025
2018
Q3 		$264K Hold
1,868
– – ﹤0.01% 932
2018
Q2 		$292K Hold
1,868
– – ﹤0.01% 888
2018
Q1 		$301K Buy
1,868
+108
+6% +$18.3K ﹤0.01% 877
2017
Q4 		$290K Sell
1,760
-1,484
-46% -$144K ﹤0.01% 903
2017
Q3 		$202K Sell
3,244
-554
-15% -$43.5K ﹤0.01% 1036
2017
Q2 		$302K Buy
3,798
+363
+11% +$26.2K ﹤0.01% 945
2017
Q1 		$244K Buy
+3,435
New +$201K ﹤0.01% 1027

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KeyBank National Association's SAGE Position: Q4 2018 in Review

KeyBank National Association sold out of Sage Therapeutics (SAGE) in Q4 2018, closing a stake of 1,868 shares — an estimated $264K sold.

KeyBank National Association first reported a position in SAGE in Q1 2017 and held it in 7 quarters. The position peaked at $302K in Q2 2017. 248 funds tracked by Wall St. Rank hold SAGE as of Q4 2018.

  • KeyBank National Association reported no remaining Sage Therapeutics position as of Q4 2018 after selling out during the quarter.
  • KeyBank National Association sold 1,868 Sage Therapeutics shares in Q4 2018, an estimated $264K.
  • KeyBank National Association first reported a position in Sage Therapeutics in Q1 2017 and held it in 7 quarters.
  • KeyBank National Association's Sage Therapeutics position peaked at $302K in Q2 2017.
  • 248 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2018.

Based on KeyBank National Association's 13F filing for Q4 2018, filed 30 Jan 2019.